Developer docs
API playgroundTry for free, no card

Search company profiles

Zorgkeuzelab

Full company profile

uuid000grwe

Namestring
Zorgkeuzelab
Legal namestring
ZorgKeuzeLab BV
Websiteurl
zorgkeuzelab.nl
Company typeenum
Private
Founded yearint
2013
Descriptiontext

Zorgkeuzelab (ZorgKeuzeLab BV) is a Dutch digital health company founded in 2013 by service designers Regina The and Klemens Karssen, headquartered in Delft. The company develops evidence-based patient decision aids ("keuzehulpen") that support shared decision-making between patients and healthcare providers across a growing portfolio of over 25 conditions spanning oncology (breast, prostate, lung, colorectal, kidney, bladder, pancreatic), cardiology (heart valve, ICD), neurology (Parkinson's, stroke), urology (BPH, incontinence), respiratory (asthma), and other specialties. Each decision aid is co-developed with relevant scientific medical societies and patient organizations, and a specialized Patient-Like-Me module for stage IV lung cancer surfaces anonymized outcome data stratified by ECOG score and PD-L1 expression to personalize treatment choice.

The underlying platform combines online interactive decision aids accessible to patients at home with companion printable handouts used in consultations, plus a team reporting system that delivers monthly and quarterly implementation metrics. Implementation is sold and delivered as a 3-9 month structured hospital engagement including team training, on-site kickoff, and ongoing coaching from a dedicated implementation coordinator.

The business operates a subscription-based model tied to hospital implementations, bundled with implementation services and continuous content updates to reflect current clinical guidelines. Pricing is not publicly disclosed; a free trial package is offered to hospitals before full subscription commitment. Zorgkeuzelab serves 52 Dutch hospitals and 200+ clinical teams, with collective case-study customers including Reinier de Graaf Gasthuis, Gelre Ziekenhuizen, Jeroen Bosch Ziekenhuis, OLVG, Erasmus MC, and Santeon hospital group. Since December 2023 the company has been a subsidiary of Performation, a larger Dutch healthcare services organization, marking its transition from independent startup to scaling phase; in February 2026 co-founder Klemens Karssen departed after 13 years, with Regina The continuing as General Director. The company has raised no institutional venture funding; non-dilutive support has included a KWF grant for nationwide lung-cancer decision aid rollout.

Short descriptiontext

Zorgkeuzelab is a Delft-based Dutch digital health company that develops and implements over 25 evidence-based patient decision aids across oncology, cardiology, neurology, and urology, serving 52 Dutch hospitals and 200+ clinical teams via a subscription and implementation-support model.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersDelft, Netherlands
HQ citystring
Delft
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
patient decision aids, shared decision making, healthcare decision support, clinical decision tools, patient engagement software
Industry2 codes
PRIMARYHLACAGAC
Order Sets, Care Plans & Clinical Pathways (CPOE-integrated)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACAEAF
Patient Intake, Digital Registration & eForms
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Decision Support Software
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Healthcare Decision Aid Subscription
TypeSubscription Recurring
Description

ZorgKeuzeLab operates on a cost-covering development model. They develop each decision aid cost-effectively and for nationwide use. The subscription model includes personal guidance during implementation, training materials, handout blocks, online access, monthly motivational reports, quarterly reports, and ongoing support to keep decision aids up-to-date with current medical guidelines.

zorgkeuzelab.nl
2Hospital Implementation Services
TypeProfessional Services
Description

Implementation support services including team training, on-site kick-off training, personal coaching from implementation coordinator Annette, and ongoing support for teams and patients.

zorgkeuzelab.nl
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations
Pricing details1 tier
1Trial Package (Proefpakket)
ModelFreemiumBilling cadenceOne time
Notes

Free trial package available for healthcare professionals to test a decision aid with their patients before full implementation

zorgkeuzelab.nl
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

ZorgKeuzeLab develops and implements evidence-based digital patient decision aids (keuzehulpen) that help patients understand their treatment options, weigh pros and cons, and prepare for consultations with healthcare providers. The portfolio covers more than 25 decision aids across oncology, cardiology, neurology, urology and other conditions, with accompanying implementation support including team training, personal coaching, monthly/quarterly reporting, and ongoing content updates.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 88% patient satisfaction rate reported for lung cancer decision aid users
+2 more records
Product overview1 text field

ZorgKeuzeLab is a digital health platform that develops and implements evidence-based decision aids (keuzehulpen) to support shared decision-making between patients and healthcare providers. The portfolio includes over 25 active decision aids across multiple medical specialties including oncology (breast cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, ovarian cancer, pancreatic cancer), cardiology (heart valve, ICD), neurology (stroke, Parkinson's), urology (BPH, overactive bladder), respiratory (asthma), and other conditions. The company also maintains a pipeline of decision aids in development for burns, high-risk breast cancer, and metastatic bladder cancer. Implementation support services include team training, monthly reporting, and ongoing support, with deployment across 52 hospitals and 200+ teams in the Netherlands.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2023-12-01
Description

ZorgKeuzeLab joined Performation in December 2023, entering an upscaling phase. Performation is a large, experienced healthcare organization that enables ZorgKeuzeLab to accelerate development and implementation of decision aids with professional structures and support.

Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2013-07-01
Description

ZorgKeuzeLab participated in the LaunchLab program at YES!Delft, a startup incubator, where founders Regina The and Klemens Karssen developed their initial business plan and presentation.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Each decision aid is developed in collaboration with relevant medical societies and expert clinicians from leading Dutch hospitals, ensuring scientific validity and clinical relevance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Patient associations are actively involved in developing decision aids, representing the patient perspective and ensuring tools meet actual patient needs for information and support.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Santeon collaborated with ZorgKeuzeLab on development and implementation of the lung cancer decision aid. Jointly developed the Patients-Like-Me module for stage IV lung cancer patients with KWF funding.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Patient organization partner in the development of the lung cancer decision aid, representing the voice of lung cancer patients.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Prof. dr. Sandra van Dulmen from Nivel serves on the Advisory Board, providing expertise in eHealth and patient participation.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Prof. dr. S. Siesling from University of Twente serves on the Advisory Board with expertise in clinical epidemiology.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Pink Ribbon co-funded the implementation research for the breast cancer decision aid developed with MUMC+.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

KWF-funded research project developing decision aids for women with elevated breast cancer risk, implemented across all academic hospitals and Antoni van Leeuwenhoek.

11Stichting Erfelijke Kanker Nederland
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Patient organization partner in the development of the decision aid for women with hereditary breast cancer risk.

zorgkeuzelab.nl
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based nonprofit that develops evidence-based patient decision aids and health content deployed across major US health systems. Most direct international comparator to ZorgKeuzeLab's evidence-based, society-co-developed decision aid model serving hospitals at scale.

TypeDirect peer
Description

Patient decision support platform that delivers personalized treatment choice tools to patients in US health systems. Directly comparable product offering (interactive shared decision-making tools) and customer base (hospitals and specialty practices).

3Option Grid (EBSCO Health)
TypeDirect peer
Description

Evidence-based patient decision aids (originally Option Grid, now part of EBSCO Health/DynaMed) covering multiple treatment options across conditions. Competes in the same SDM/decision aid category with similar evidence-based development methodology.

4Shared Decision Making aids via Mayo Clinic / Mayo Clinic Shared Decision Making National Resource Center
TypeBroad incumbent
Description

Mayo Clinic's SDM program develops decision aids and trains clinicians nationally. Comparable in clinical credibility and content development methodology, though embedded within a much larger academic medical institution rather than an independent vendor.

TypeBroad incumbent
Description

Large US patient engagement platform delivering education and decision support content in physician offices and health systems. Adjacent in patient engagement category with overlapping hospital customer base and content-driven approach.

TypeBroad incumbent
Description

Global health information provider whose UpToDate and clinical decision tools are used in Dutch and European hospitals. Broad incumbent with overlapping clinical decision support content and direct hospital relationships that compete for SDM mindshare.

7Elsevier (ClinicalPath / patient engagement)
TypeBroad incumbent
Description

Major medical publisher and clinical decision support vendor with patient-facing tools and care pathway products. Comparable as broad incumbent with content depth and hospital distribution that could expand into SDM space.

TypeOthers
Description

Parent company of ZorgKeuzeLab since December 2023; Dutch healthcare consultancy focused on Value Based Healthcare. Parent/owner relationship, but also comparable as Dutch healthcare process innovation consultant supporting hospital quality improvement.

TypeOthers
Description

Dominant Dutch EHR vendor (HiX) used by most Dutch hospitals. Indirect competitor/potential channel partner, as EHR-embedded SDM modules could compete with or integrate ZorgKeuzeLab's standalone platform.

TypeEmerging player
Description

AI-driven symptom checker and digital health triage platform used by insurers and health systems across Europe. Adjacent emerging player in patient-facing clinical decision tools with comparable enterprise health customer model and European footprint.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Zorgkeuzelab

Healthcare Decision Support Softwarezorgkeuzelab.nl

Zorgkeuzelab is a Delft-based Dutch digital health company that develops and implements over 25 evidence-based patient decision aids across oncology, cardiology, neurology, and urology, serving 52 Dutch hospitals and 200+ clinical teams via a subscription and implementation-support model.

What Zorgkeuzelab does

Zorgkeuzelab (ZorgKeuzeLab BV) is a Dutch digital health company founded in 2013 by service designers Regina The and Klemens Karssen, headquartered in Delft. The company develops evidence-based patient decision aids ("keuzehulpen") that support shared decision-making between patients and healthcare providers across a growing portfolio of over 25 conditions spanning oncology (breast, prostate, lung, colorectal, kidney, bladder, pancreatic), cardiology (heart valve, ICD), neurology (Parkinson's, stroke), urology (BPH, incontinence), respiratory (asthma), and other specialties. Each decision aid is co-developed with relevant scientific medical societies and patient organizations, and a specialized Patient-Like-Me module for stage IV lung cancer surfaces anonymized outcome data stratified by ECOG score and PD-L1 expression to personalize treatment choice.

The underlying platform combines online interactive decision aids accessible to patients at home with companion printable handouts used in consultations, plus a team reporting system that delivers monthly and quarterly implementation metrics. Implementation is sold and delivered as a 3-9 month structured hospital engagement including team training, on-site kickoff, and ongoing coaching from a dedicated implementation coordinator.

The business operates a subscription-based model tied to hospital implementations, bundled with implementation services and continuous content updates to reflect current clinical guidelines. Pricing is not publicly disclosed; a free trial package is offered to hospitals before full subscription commitment. Zorgkeuzelab serves 52 Dutch hospitals and 200+ clinical teams, with collective case-study customers including Reinier de Graaf Gasthuis, Gelre Ziekenhuizen, Jeroen Bosch Ziekenhuis, OLVG, Erasmus MC, and Santeon hospital group. Since December 2023 the company has been a subsidiary of Performation, a larger Dutch healthcare services organization, marking its transition from independent startup to scaling phase; in February 2026 co-founder Klemens Karssen departed after 13 years, with Regina The continuing as General Director. The company has raised no institutional venture funding; non-dilutive support has included a KWF grant for nationwide lung-cancer decision aid rollout.

Zorgkeuzelab firmographics

Firmographics
Name
Zorgkeuzelab
Legal name
ZorgKeuzeLab BV
Website
https://zorgkeuzelab.nl
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
1–10 employees
Short description
Zorgkeuzelab is a Delft-based Dutch digital health company that develops and implements over 25 evidence-based patient decision aids across oncology, cardiology, neurology, and urology, serving 52 Dutch hospitals and 200+ clinical teams via a subscription and implementation-support model.
Ownership category
akta.pro rank

Zorgkeuzelab industry classification

Industry
Product category
Healthcare Decision Support Software
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Management Consulting Services (8742)
akta.pro industry
PRIMARYHLACAGAC
Order Sets, Care Plans & Clinical Pathways (CPOE-integrated)
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
SECONDARYHLACAEAF
Patient Intake, Digital Registration & eForms
Healthcare & Life Sciences/Digital Health & Health IT/Patient Engagement, CRM & Experience Platforms

Keywords

  • Patient decision aids
  • Shared decision making
  • Healthcare decision support
  • Clinical decision tools
  • Patient engagement software

Where Zorgkeuzelab is headquartered

Location

Headquarters

HQ city
Delft
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Zorgkeuzelab business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Infrastructure, Operations

Revenue model

  1. Healthcare Decision Aid Subscription: ZorgKeuzeLab operates on a cost-covering development model. They develop each decision aid cost-effectively and for nationwide use. The subscription model includes personal guidance during implementation, training materials, handout blocks, online access, monthly motivational reports, quarterly reports, and ongoing support to keep decision aids up-to-date with current medical guidelines.
  2. Hospital Implementation Services: Implementation support services including team training, on-site kick-off training, personal coaching from implementation coordinator Annette, and ongoing support for teams and patients.

Pricing tiers

ModelBillingPrice
FreemiumOne timeTrial Package (Proefpakket)

Go-to-market motion2 records

Distribution channels1 record

Marketing channels5 records

Zorgkeuzelab product offering

Product offering

Core offering

ZorgKeuzeLab develops and implements evidence-based digital patient decision aids (keuzehulpen) that help patients understand their treatment options, weigh pros and cons, and prepare for consultations with healthcare providers. The portfolio covers more than 25 decision aids across oncology, cardiology, neurology, urology and other conditions, with accompanying implementation support including team training, personal coaching, monthly/quarterly reporting, and ongoing content updates.

Product overview

ZorgKeuzeLab is a digital health platform that develops and implements evidence-based decision aids (keuzehulpen) to support shared decision-making between patients and healthcare providers. The portfolio includes over 25 active decision aids across multiple medical specialties including oncology (breast cancer, prostate cancer, colorectal cancer, lung cancer, kidney cancer, ovarian cancer, pancreatic cancer), cardiology (heart valve, ICD), neurology (stroke, Parkinson's), urology (BPH, overactive bladder), respiratory (asthma), and other conditions. The company also maintains a pipeline of decision aids in development for burns, high-risk breast cancer, and metastatic bladder cancer. Implementation support services include team training, monthly reporting, and ongoing support, with deployment across 52 hospitals and 200+ teams in the Netherlands.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 88% patient satisfaction rate reported for lung cancer decision aid users
  • +2 more outcomes

Companies that use Zorgkeuzelab

Customer profile

Named customers10 records

Segments1 record

Ideal customer profiles2 records

Zorgkeuzelab technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Zorgkeuzelab partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core and minor.

  • PerformationcoreStrategic or Co-development Partner · 1 December 2023ZorgKeuzeLab joined Performation in December 2023, entering an upscaling phase. Performation is a large, experienced healthcare organization that enables ZorgKeuzeLab to accelerate development and implementation of decision aids with professional structures and support.
  • YES!DelftminorStrategic or Co-development Partner · 1 July 2013ZorgKeuzeLab participated in the LaunchLab program at YES!Delft, a startup incubator, where founders Regina The and Klemens Karssen developed their initial business plan and presentation.
  • Scientific Medical SocietiescoreStrategic or Co-development PartnerEach decision aid is developed in collaboration with relevant medical societies and expert clinicians from leading Dutch hospitals, ensuring scientific validity and clinical relevance.
  • Patient OrganizationscoreStrategic or Co-development PartnerPatient associations are actively involved in developing decision aids, representing the patient perspective and ensuring tools meet actual patient needs for information and support.
  • SanteoncoreStrategic or Co-development PartnerSanteon collaborated with ZorgKeuzeLab on development and implementation of the lung cancer decision aid. Jointly developed the Patients-Like-Me module for stage IV lung cancer patients with KWF funding.
  • Longkanker NederlandcoreStrategic or Co-development PartnerPatient organization partner in the development of the lung cancer decision aid, representing the voice of lung cancer patients.
  • NivelminorStrategic or Co-development PartnerProf. dr. Sandra van Dulmen from Nivel serves on the Advisory Board, providing expertise in eHealth and patient participation.
  • University of TwenteminorStrategic or Co-development PartnerProf. dr. S. Siesling from University of Twente serves on the Advisory Board with expertise in clinical epidemiology.
  • Pink RibbonminorStrategic or Co-development PartnerPink Ribbon co-funded the implementation research for the breast cancer decision aid developed with MUMC+.
  • OPTIONS Study (KWF funded)coreStrategic or Co-development PartnerKWF-funded research project developing decision aids for women with elevated breast cancer risk, implemented across all academic hospitals and Antoni van Leeuwenhoek.
  • Stichting Erfelijke Kanker NederlandcoreStrategic or Co-development PartnerPatient organization partner in the development of the decision aid for women with hereditary breast cancer risk.

Scale indicators7 records

Recent moves7 records

Expansion highlights5 records

Zorgkeuzelab competitors and assessment

Company assessment

Direct peers

  • Healthwise: US-based nonprofit that develops evidence-based patient decision aids and health content deployed across major US health systems. Most direct international comparator to ZorgKeuzeLab's evidence-based, society-co-developed decision aid model serving hospitals at scale.
  • WiserCare: Patient decision support platform that delivers personalized treatment choice tools to patients in US health systems. Directly comparable product offering (interactive shared decision-making tools) and customer base (hospitals and specialty practices).
  • Option Grid (EBSCO Health): Evidence-based patient decision aids (originally Option Grid, now part of EBSCO Health/DynaMed) covering multiple treatment options across conditions. Competes in the same SDM/decision aid category with similar evidence-based development methodology.

Broad incumbents

  • Shared Decision Making aids via Mayo Clinic / Mayo Clinic Shared Decision Making National Resource Center: Mayo Clinic's SDM program develops decision aids and trains clinicians nationally. Comparable in clinical credibility and content development methodology, though embedded within a much larger academic medical institution rather than an independent vendor.
  • PatientPoint: Large US patient engagement platform delivering education and decision support content in physician offices and health systems. Adjacent in patient engagement category with overlapping hospital customer base and content-driven approach.
  • Wolters Kluwer (UpToDate Decision Aids): Global health information provider whose UpToDate and clinical decision tools are used in Dutch and European hospitals. Broad incumbent with overlapping clinical decision support content and direct hospital relationships that compete for SDM mindshare.
  • Elsevier (ClinicalPath / patient engagement): Major medical publisher and clinical decision support vendor with patient-facing tools and care pathway products. Comparable as broad incumbent with content depth and hospital distribution that could expand into SDM space.

Others

  • Performation: Parent company of ZorgKeuzeLab since December 2023; Dutch healthcare consultancy focused on Value Based Healthcare. Parent/owner relationship, but also comparable as Dutch healthcare process innovation consultant supporting hospital quality improvement.
  • ChipSoft (HiX EHR): Dominant Dutch EHR vendor (HiX) used by most Dutch hospitals. Indirect competitor/potential channel partner, as EHR-embedded SDM modules could compete with or integrate ZorgKeuzeLab's standalone platform.

Emerging players

  • Infermedica: AI-driven symptom checker and digital health triage platform used by insurers and health systems across Europe. Adjacent emerging player in patient-facing clinical decision tools with comparable enterprise health customer model and European footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Zorgkeuzelab social profiles

Digital presence

Zorgkeuzelab compliance and trust

Trust signal

Compliance5 records

Zorgkeuzelab financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Zorgkeuzelab leadership team

Management profile

Number of profiles

Profiles8 records

Zorgkeuzelab funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Zorgkeuzelab M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zorgkeuzelab

What does Zorgkeuzelab do?

ZorgKeuzeLab develops and implements evidence-based digital patient decision aids (keuzehulpen) that help patients understand their treatment options, weigh pros and cons, and prepare for consultations with healthcare providers. The portfolio covers more than 25 decision aids across oncology, cardiology, neurology, urology and other conditions, with accompanying implementation support including team training, personal coaching, monthly/quarterly reporting, and ongoing content updates.

Is Zorgkeuzelab a public or private company?

Zorgkeuzelab is a private company. It is classified as corporate owned and is currently operating.

When was Zorgkeuzelab founded?

Zorgkeuzelab was founded in 2013. It employs 1 to 10 people.

Where is Zorgkeuzelab based?

Zorgkeuzelab is headquartered in Delft, Netherlands, in the Europe region.

How does Zorgkeuzelab make money?

Two revenue lines are on record. Healthcare Decision Aid Subscription is the primary driver. The others are hospital Implementation Services.

Who are Zorgkeuzelab's main competitors?

Direct peers on record are Healthwise, WiserCare and Option Grid (EBSCO Health). Broad incumbents are Shared Decision Making aids via Mayo Clinic / Mayo Clinic Shared Decision Making National Resource Center, PatientPoint, Wolters Kluwer (UpToDate Decision Aids) and Elsevier (ClinicalPath / patient engagement). Others are Performation and ChipSoft (HiX EHR). Infermedica is listed as an emerging player.

Does Zorgkeuzelab have an API?

No public API is recorded for Zorgkeuzelab.

What industry is Zorgkeuzelab in?

Zorgkeuzelab's product category is Healthcare Decision Support Software. Its primary akta.pro industry code is HLACAGAC, Order Sets, Care Plans & Clinical Pathways (CPOE-integrated), with a secondary code of HLACAEAF, Patient Intake, Digital Registration & eForms. Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals